Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion type Assertion NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_head.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion description "[All patients, who were on the standard treatment protocol, were subsequently divided into two groups according to their genotype, group A (92): TM with no mitigating factor and group B (34): TM carrying one or more mitigating factors in the beta- and/or alpha-globin genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_provenance.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion evidence source_evidence_literature NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_provenance.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion SIO_000772 16800840 NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_provenance.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion wasDerivedFrom befree-20150227 NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_provenance.
- NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_assertion wasGeneratedBy ECO_0000203 NP443857.RAOMXdHFMUwLM6-8yccZY4gXlLGq-Tk3anC5PDKIfhlIk130_provenance.